
Pharmaceutical company Ephar has obtained registration for its Cannabidiol in two concentrations, 50 mg/mL and 100 mg/mL, which will be marketed in a low THC content drop solution.

Study from Imperial College London reveals that the use of psychedelics during the COVID-19 pandemic was associated with improvement in symptoms of anxiety and depression, even outside of controlled therapeutic contexts

Learn how small changes can minimize harm and promote a healthier experience when consuming cannabis

Does marijuana damage the lungs? This is one of the mysteries that science is still trying to unravel. There is not enough data on what the effects on the organ are, however, a recent study indicated that adult use is not associated with impairment

The intention of the state foundation, maintained by the Federal Government, stands out due to the fact that, currently, the cultivation of the Cannabis sativa plant is prohibited by Brazilian legislation

Estudos publicados nos Estados Unidos e no Reino Unido indicam que o uso de cannabis pode afetar o cérebro de forma distinta na vida adulta e no envelhecimento

Proposal put forth by Republican senators aims to block the use of federal resources to reschedule cannabis in the United States

Unanimous decision by the Fifth Panel reinforces patients' right to therapeutic planting upon medical proof and highlights the topic in an official report

Public call aims to gather scientific evidence to support the regulation of Cannabis cultivation for medicinal and pharmaceutical purposes in Brazil

Preventive action involves imported and national items and reinforces rules for restricted disclosure to doctors and pharmacists

Thiago Campos advocates for the extension of the regulation deadline and reinforces the importance of social listening in the process

Discover in the Sechat Guide how medicinal cannabis is transforming animal health, bringing relief and quality of life to pets and large animals

Alesc discusses agreements, professional training, and cultivation by family farming

PL 569/2021, which provides for the supply of cannabidiol-based medications in public and affiliated units, has a favorable opinion in the Health Committee

Resolution RN 623/2024 imposes new requirements on operators and improves traceability in user service

Study indicates that cannabidiol (CBD) reduces compulsive behaviors without causing sedation or impairing mobility

Psychologist Lauro Pontes analyzes the largest study on cannabis and OCD, shares scientific evidence, and explains how the plant can alleviate symptoms such as anxiety, compulsions, and intrusive thoughts.

The Ministry of Agriculture is finalizing a technical note related to the bill currently in the Senate

The anxiolytic power of CBD can assist in relaxation, reducing anxiety and fear

Study conducted in the Netherlands interviewed 367 people; most of them do not discuss the use of natural products with their doctors in treating Parkinson's